Navigation Links
Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow -

DOYLESTOWN, Pa., June 20, 2007 /PRNewswire-FirstCall/ -- Quigley Pharma, www.QuigleyPharma.com, a wholly owned subsidiary of The Quigley Corporation announced today that it has completed a follow-up study to evaluate the impact of QR-443 on levels of a pro-inflammatory cytokine Interleukin-6 (IL-6) in a cachexia model. This new data concluded that responding mice had lower levels of serum IL-6 when administered QR-443 orally than mice that received placebo. This reduction in IL-6 suggests a method of action for the delayed onset and reduced severity of cachexia observed in this study as well as the previously conducted cachexia model study.

QR-443 was formulated with the intention to impact metabolic imbalances and chronic inflammation. Cachexia is an extremely debilitating and life threatening, wasting syndrome associated with chronic diseases such as cancer, AIDS, chronic renal failure, COPD and rheumatoid arthritis, where inflammation has a significant impact and patients experience loss of weight, muscle atrophy, fatigue, weakness and decreased appetite.

A reduction in IL-6 is associated with a reduction in inflammation and suggests that QR-443 may have a role in a broad range of chronic inflammatory diseases. The Company has begun developing a human study protocol to evaluate the safety and impact of this compound on specific metabolic processes altered by chronic inflammation and the presence of IL-6.

Chronic inflammation is also associated with other disorders such as rheumatoid arthritis, metabolic syndrome, COPD, AIDS and cancer and can cause physical, metabolic and physiological limitations. Interleukin-6 (IL-6) is a pro-inflammatory cytokine secreted to stimulate an immune response to trauma and disease leading to inflammation. Inflammation and the presence of IL-6 have been shown to negatively effect "normal" metabolic
'"/>




Page: 1 2 3 4

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
9. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
10. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
Post Your Comments:
(Date:7/7/2015)... Calif. , July 7, 2015  Essentialis, a venture-backed ... agonists for the treatment of orphan neurobehavioral and metabolic diseases, ... and CSO, will present a corporate update at the Cantor ... Conference Date: Wednesday, July 8, 2015 Time: ... About Essentialis, Inc. ...
(Date:7/7/2015)... NEW YORK , July 7, 2015 ... new generation of drugs within human and veterinary oncology, ... the Securities and Exchange Commission, in connection with the ... the NASDAQ Stock Market. The number of American Depositary ... price range for the offering have not yet been ...
(Date:7/7/2015)... Ill. , July 7, 2015  Monopar Therapeutics ... oncology compounds, announced that its co-founder and CEO, ... British Council,s Education U.K. Alumni Entrepreneurial Award. The British ... China , India , and ... recognizes outstanding achievements made by entrepreneurs who have leveraged ...
Breaking Medicine Technology:Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... 2011 Scientists at Osel Inc . and ... a new way to prevent HIV infection by genetically ... block viral transmission. Bioengineered bacteria introduced into the vaginal ... of simian HIV (SHIV) by nearly two thirds. ...
... July 18, 2011 Data from high-risk patients requiring ... nondeferrable, non-cardiac surgery show good short- and long-term clinical ... according to a study published online on the journal ... In the single-center study, patients treated with the Genous ...
Cached Medicine Technology:Scientists Use Live Bacteria to Fight HIV 2Scientists Use Live Bacteria to Fight HIV 3OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 2OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 3
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Ticket Down is a reputable source of ... vs. Haiti and Panama vs. Honduras at the Gillette Stadium in Foxborough, Massachusetts. , The ... will take place at Gillette Stadium in Foxborough, MA. The matches will be held on ...
(Date:7/7/2015)... ... 07, 2015 , ... Today, the physicians at Allied Anesthesia, who provide services ... San Bernardino counties, released a series of tips to help children stay safe over ... children, who spend more unsupervised time outdoors. , The most common causes of ...
(Date:7/7/2015)... Wisconsin (PRWEB) , ... July 07, 2015 , ... Owners ... Best of Madison winners in the home service category. This honor can only be ... is growing because of the safety of the products and methods they use daily. ...
(Date:7/7/2015)... Norfolk, NE (PRWEB) , ... July 07, 2015 ... ... imaging center for MRI services, is debuting their brand new website. The website’s ... MRI technology and a wider selection of patient tools, including requesting appointments online. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix ... CelestixEdge VE and CelestixFederated VA Series virtual appliances. These virtual platforms expand ... of products, which have proven to simplify the on-premises deployment of unified remote ...
Breaking Medicine News(10 mins):Health News:CONCACAF Group A Tickets: USA vs. Haiti & Honduras vs. Panama at Gillette Stadium: Ticket Down Slashes CONCACAF Gold Cup Group A Tickets in Foxborough 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4
... HARRISBURG, Pa., April 27 Makenzie ... Hungary Regional School in Northampton County, will receive ... the Pennsylvania Dental Association,s (PDA) 2009 National Children,s ... will be reproduced as bookmarks, which will be ...
... Inc. (Nasdaq: CRDC ) today announced that it ... March 31, 2009, on Monday, May 4, 2009, after the ... 4:30 p.m. Eastern Time to discuss the financial results and ... Details , To access the live conference call ...
... care at community health clinics especially women ... cardiologist than those who receive primary care at hospitals, ... the American Heart Association . , Researchers from the ... Medical School reviewed the electronic medical records of 9,761 ...
... Lunch into a Walking Lunch April 29 PITTSBURGH, April 27 ... and, to burn the calories in an average candy bar, ... football field 33 times. Experts agree on the many health ... one of the easiest and most inexpensive ways to exercise. ...
... Med Tech, Inc. (Pink Sheets: RBRM) today offered ... flu based on the germ killing power of ... ) "We spent the entire weekend ... boxed in pre-paid overnight FED-EX boxes," said David ...
... April 27 Lung Cancer Alliance announced that ... lung cancer,s high mortality rate was introduced with ... Representatives today.(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ... comprehensive, multi-agency approach to lung cancer in both ...
Cached Medicine News:Health News:Pennsylvania Dental Association Announces Winners of Annual Statewide Third-Grade Student Poster Contest 2Health News:Cardica to Announce Fiscal 2009 Third Quarter Financial Results on Monday, May 4, 2009 2Health News:Patients at community health clinics less likely to be referred to cardiologist 2Health News:Patients at community health clinics less likely to be referred to cardiologist 3Health News:Highmark Puts Employee Health First on National Walk@Lunch Day 2Health News:Highmark Puts Employee Health First on National Walk@Lunch Day 3Health News:'Nano-Silver Swine Flu Protection' 2Health News:'Nano-Silver Swine Flu Protection' 3Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 2Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: